ArticleEClinicalMedicine2025

Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial.

Roger Lobo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.